Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0FFHVO
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
AU2023279443A1 Comparative Control Compound-2
|
|||||
| Synonyms |
AU2023279443A1 Comparative Control Compound-2
Click to Show/Hide
|
|||||
| Organization |
UBE CORPORATION
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
Eribulin
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Mal-PEG2-Val-Cit-PAB
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
Mal-PEG2-Val-Cit-PAB-Eribulin
|
|||||